Sector Focus
Biotechnology
Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.
Clients
- Adolor Corporation (Now Cubist Pharmaceuticals)
- Advanced Tissue Sciences, Inc.
- Alpha Therapeutic Corporation (now Grifols)
- Applied Immune Sciences, Inc. (now Sanofi-Aventis)
- Armour Pharmaceutical Co. (now CSL Behring)
- Avalon Pharmaceuticals, Inc. (now Clinical Data Inc.)
- Bayer Healthcare Pharmaceuticals, Inc.
- BioChem Pharma, Inc.
- Cell Genesys, Inc. (Now BioSante Pharmaceuticals)
- Cell Therapeutics, Inc.
- Centocor, Inc. (Now Janssen Biotech)
- Cephalon, Inc. (Now Teva Pharmaceuticals)
- Ceregene, Inc.
- CFY BioMedicals, Inc. (later renamed Perlan Therapeutics)
- CIMA Labs, Inc. (now Teva Pharmaceuticals)
- CoCensys, Inc. (now Purdue)
- Coley Pharmaceutical Group, Inc. (now Pfizer)
- Conforma Therapeutics Corporation (now Biogen Idec)
- Corixa Corporation (now GSK)
- Coulter Pharmaceuticals, Inc. (now GSK)
- Curagen Corporation (Now Celldex Therapeutics)
- Enchira Biotechnology Corporation
- Enzon, Inc.
- GenStar Therapeutics Corporation (now VIA Pharmaceuticals)
- Genzyme Corporation
- Immunization Products, Ltd.
- Isis Pharmaceuticals, Inc.
- Koronis Pharmaceuticals, Inc.
- MedImmune, Inc.
- Myriad Genetics, Inc.
- Novartis
- Paratek Pharmaceuticals, Inc.
- PaxVax, Inc.
- Pharmion Corporation (now Celgene)
- Repligen Corporation
- RPR-Gencell
- Salmedix, Inc. (now Teva Pharmaceuticals)
- Schein Pharmaceuticals, Inc. (now Watson Laboratories)
- Selective Genetics, Inc.
- Sepracor, Inc. (Now Sunovion)
- SGX Pharmaceuticals, Inc. (now Pfizer)
- SmithKline Beecham Corporation (now GlaxoSmithKline)
- Sonus Pharmaceuticals (now OncoGenex Pharmaceuticals)
- Sugen, Inc. (now Pfizer)
- VaxInnate Corporation
- Versicor, Inc. (now Pfizer)
- Vertex Pharmaceuticals, Inc.
- Vical, Inc.
- ViroPharma, Inc.
- Zeneca, Inc. (now AstraZeneca)
Genzyme Corporation
Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopedics, transplant, cancer, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial research and development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.
Search Projects
- Senior Vice President, Medical Affairs
- Vice President and Allston Landing Site Manager
- Group Vice President, Drug Discovery
- Vice President, Orthopaedic Research
- Vice President, Oncology Research
- Senior Vice President, Global Clinical Operations
- Senior Vice President, Global Product Quality
- Medical Director – Cardiovascular
- Vice President Quality – Site Leader
- Senior Director Quality Assurance